Chaofeng Dai - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Chaofeng Dai

Showing results (21-30 of 25) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 25 results.

Chemmedchem|November 27, 2015

Design, Synthesis and Evaluation of Triazole-Pyrimidine Analogues as SecA InhibitorsJianmei Cui, Jinshan Jin, Arpana Sagwal Chaudhary, et al.

Chemical Communications (Cambridge, England)|August 20, 2011

Using boronolectin in MALDI-MS imaging for the histological analysis of cancer tissue expressing the sialyl Lewis X antigenChaofeng Dai, Lisa H Cazares, Lifang Wang, et al.

Chemmedchem|October 19, 2016

Using Chemical Probes to Assess the Feasibility of Targeting SecA for Developing Antimicrobial Agents against Gram-Negative BacteriaJinshan Jin, Ying-Hsin Hsieh, Jianmei Cui, et al.

Bioorganic & Medicinal Chemistry|July 21, 2019

Upregulation of p53 through induction of MDM2 degradation: Anthraquinone analogsAlexander B Draganov, Xiaoxiao Yang, Abiodun Anifowose, et al.

Cancer Research|September 24, 2025

PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated CancersMichael Hulse, Min Wang, Chaoyi Xu, et al.

Pageof 3

Search research articles

Showing results (21-30 of 25) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 25 results.

Chemmedchem|November 27, 2015

Design, Synthesis and Evaluation of Triazole-Pyrimidine Analogues as SecA InhibitorsJianmei Cui, Jinshan Jin, Arpana Sagwal Chaudhary, et al.

Chemical Communications (Cambridge, England)|August 20, 2011

Using boronolectin in MALDI-MS imaging for the histological analysis of cancer tissue expressing the sialyl Lewis X antigenChaofeng Dai, Lisa H Cazares, Lifang Wang, et al.

Chemmedchem|October 19, 2016

Using Chemical Probes to Assess the Feasibility of Targeting SecA for Developing Antimicrobial Agents against Gram-Negative BacteriaJinshan Jin, Ying-Hsin Hsieh, Jianmei Cui, et al.

Bioorganic & Medicinal Chemistry|July 21, 2019

Upregulation of p53 through induction of MDM2 degradation: Anthraquinone analogsAlexander B Draganov, Xiaoxiao Yang, Abiodun Anifowose, et al.

Cancer Research|September 24, 2025

PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated CancersMichael Hulse, Min Wang, Chaoyi Xu, et al.

Pageof 3